All Posts
Guideline | Management of vagus nerve stimulation therapy in the peri-operative period
11 May, 2023 | 12:08h | UTCManagement of vagus nerve stimulation therapy in the peri-operative period – Anaesthesia
M-A | Intensive blood pressure control for patients aged over 60
11 May, 2023 | 12:07h | UTC
RCT | Safety and efficacy of zilucoplan in patients with generalized myasthenia gravis
11 May, 2023 | 12:04h | UTCSafety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study – The Lancet Neurology (link to abstract – $ for full-text)
News Release: Researchers report on rozanolixizumab, zilucoplan phase 3 myasthenia gravis study – MedicalXpress
How to recognize a trustworthy clinical practice guideline
11 May, 2023 | 12:03h | UTC
M-A | Fruit and vegetable consumption and the risk of hypertension
11 May, 2023 | 12:02h | UTC
M-A | Prehabilitation for patients undergoing orthopedic surgery
11 May, 2023 | 12:00h | UTC
SR | Perampanel add‐on for drug‐resistant focal epilepsy
11 May, 2023 | 11:55h | UTCPerampanel add‐on for drug‐resistant focal epilepsy – Cochrane Library
Summary: Perampanel add-on for drug-resistant focal epilepsy – Cochrane Library
Commentary on Twitter
? Perampanel add‐on for drug‐resistant focal #epilepsy
? Evidence from 7 trials involving 2,524 participants
"…effective @ reducing seizure frequency & may maintain seizure freedom…Perampanel is well‐tolerated at doses of 8 mg/day or less."https://t.co/LSJoYeDi8S— The Cochrane Library (@CochraneLibrary) April 17, 2023
Review | Perioperative glycemic management in adults presenting for elective cardiac and non-cardiac surgery
11 May, 2023 | 11:54h | UTCRelated:
Guideline Summary: New guidance on the perioperative management of diabetes.
Perioperative Evaluation and Management of Endocrine Disorders – Mayo Clinic Proceedings
Uncertainties and controversies in axillary management of patients with breast cancer
11 May, 2023 | 11:53h | UTC
Autism spectrum disorders in adulthood: symptoms, diagnosis, and treatment
11 May, 2023 | 11:51h | UTC
Olfactory dysfunction: etiology, diagnosis, and treatment
11 May, 2023 | 11:50h | UTCOlfactory Dysfunction: Etiology, Diagnosis, and Treatment – Deutsches Ärzteblatt International
Neurosurgical interventions for cerebral metastases of solid tumors
11 May, 2023 | 11:48h | UTC
Review | Radiation exposure in computed tomography
11 May, 2023 | 11:47h | UTCRadiation Exposure in Computed Tomography – Deutsches Ärzteblatt International
Recent advances in the management of primary sclerosing cholangitis
11 May, 2023 | 11:45h | UTCRelated:
AASLD Practice Guidance on Primary Sclerosing Cholangitis and Cholangiocarcinoma – Hepatology
A consensus integrated care pathway for patients with primary biliary cholangitis.
Biliary Endoscopy in the Management of Primary Sclerosing Cholangitis and its Complications
Decentralized clinical trials: ethical opportunities and challenges
11 May, 2023 | 11:44h | UTCDecentralised clinical trials: ethical opportunities and challenges – The Lancet Digital Health
Related:
Decentralized clinical trials: Collaboration is needed to drive their adoption and impact – STAT
SR | Same-day discharge vs. standard enhanced recovery after surgery (ERAS) protocols for major colorectal surgery
11 May, 2023 | 11:43h | UTC
Podcast | Hypercoagulable work-up
11 May, 2023 | 11:41h | UTC#391 Hypercoagulable Work-Up with Dr. Jean Connors – The Curbsiders
RCT | Long versus short peroral endoscopic myotomy for the treatment of achalasia
11 May, 2023 | 11:40h | UTCLong versus short peroral endoscopic myotomy for the treatment of achalasia: results of a non-inferiority randomised controlled trial – Gut (link to abstract – $ for full-text)
Care plan for individuals at risk for preeclampsia: shared approach to education, strategies for prevention, surveillance and follow up
10 May, 2023 | 16:04h | UTCCommentary: Care Plan Developed for Individuals at Risk for Preeclampsia – HealthDay
Review | Diagnosis and management of cirrhosis and its complications
10 May, 2023 | 16:06h | UTCDiagnosis and Management of Cirrhosis and Its Complications: A Review – JAMA (free for a limited period)
Author Interview: Management of Cirrhosis in 2023
M-A | Association of SARS-CoV-2 vaccination or infection with Bell palsy
10 May, 2023 | 16:03h | UTC
Single-arm study | Halting endocrine therapy for pregnancy not linked to increased breast cancer events vs. a control cohort
10 May, 2023 | 16:01h | UTCInterrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary on Twitter
In women with previous breast cancer who temporarily discontinued adjuvant endocrine therapy to attempt pregnancy, the frequency of breast cancer events was below the prespecified safety threshold and similar to that in controls (POSITIVE trial). https://t.co/zM3f4SbgjE
— NEJM (@NEJM) May 3, 2023
FDA warns of use of selective androgen receptor modulators (SARMs) among teens, young adults
10 May, 2023 | 16:00h | UTCCommentaries:
FDA issues warning for bodybuilding products marketed to teens, young adults – AAP News
Young Men Are Using Banned ‘SARM’ Supplements to Bulk Up, With Harmful Results – HealthDay
RCT | Cognitive functional therapy with or without biofeedback outperforms usual care for chronic low back pain relief
10 May, 2023 | 15:58h | UTCCognitive functional therapy with or without movement sensor biofeedback versus usual care for chronic, disabling low back pain (RESTORE): a randomised, controlled, three-arm, parallel group, phase 3, clinical trial – The Lancet (link to abstract – $ for full-text)
News Release: Fresh hope for Australians living with chronic back pain – Curtin University
Atrial fibrillation incidence associated with exposure to anticancer drugs used as monotherapy in clinical trials
10 May, 2023 | 15:54h | UTCEditorials:
Atrial Fibrillation With Modern Cancer Treatment: More Common Than We Think – JACC: CardioOncology
Commentary on Twitter
Annual incidence rate of #AFib assoc w/ anticancer drugs were ⬆️ in pts w/ hematologic malig. It was found for #ibrutinib 4.92 (95% CI: 2.91-8.31), #clofarabine 2.38 (95% CI: 0.66-8.55), & #ponatinib 2.35 (95% CI: 1.78-3.12) per 100 person-yrs https://t.co/W2RGMrE37F… pic.twitter.com/NnbmUVcci5
— JACC Journals (@JACCJournals) April 27, 2023